Pacific Biosciences of California (PACB) — Net Asset Quality Index
Pacific Biosciences of California (PACB) has a Net Asset Quality Index of 13.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $782.37 Million minus total liabilities of $677.60 Million yields net assets of $104.77 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Pacific Biosciences of California liquidity resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Pacific Biosciences of California Net Asset Quality Index Over Time (2008–2025)
This chart shows how Pacific Biosciences of California's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the index stands at 13.4%, representing net assets of $104.77 Million against total assets of $782.37 Million USD. See Pacific Biosciences of California current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Pacific Biosciences of California (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Pacific Biosciences of California from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Pacific Biosciences of California market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 0.7% | $5.35 Million | $784.08 Million | $778.73 Million | ▼ -39.5 pp |
| 2024 | 40.2% | $506.59 Million | $1.26 Billion | $753.85 Million | ▲ +0.0 pp |
| 2023 | 40.2% | $701.30 Million | $1.75 Billion | $1.04 Billion | ▲ +8.3 pp |
| 2022 | 31.9% | $562.90 Million | $1.77 Billion | $1.20 Billion | ▼ -7.6 pp |
| 2021 | 39.4% | $790.99 Million | $2.01 Billion | $1.22 Billion | ▼ -41.6 pp |
| 2020 | 81.0% | $335.49 Million | $413.98 Million | $78.49 Million | ▲ +43.9 pp |
| 2019 | 37.1% | $54.92 Million | $147.99 Million | $93.07 Million | ▼ -29.9 pp |
| 2018 | 67.0% | $114.06 Million | $170.28 Million | $56.21 Million | ▲ +7.2 pp |
| 2017 | 59.8% | $86.10 Million | $144.08 Million | $57.98 Million | ▼ -1.6 pp |
| 2016 | 61.4% | $84.67 Million | $137.88 Million | $53.22 Million | ▲ +5.3 pp |
| 2015 | 56.1% | $73.54 Million | $131.11 Million | $57.57 Million | ▲ +12.0 pp |
| 2014 | 44.1% | $54.95 Million | $124.52 Million | $69.57 Million | ▼ -6.7 pp |
| 2013 | 50.8% | $69.18 Million | $136.19 Million | $67.00 Million | ▼ -33.5 pp |
| 2012 | 84.3% | $109.38 Million | $129.68 Million | $20.30 Million | ▼ -3.4 pp |
| 2011 | 87.7% | $191.46 Million | $218.32 Million | $26.85 Million | ▼ -3.8 pp |
| 2010 | 91.5% | $279.87 Million | $305.75 Million | $25.88 Million | ▲ +266.7 pp |
| 2009 | -175.2% | $-177.12 Million | $101.10 Million | $278.22 Million | ▼ -92.6 pp |
| 2008 | -82.6% | $-93.39 Million | $113.11 Million | $206.50 Million | — |